Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined array key "thumbnail" in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 25
StackHealth / ML model uses DNA methylation to identify cancers' tissue of origin

A machine learning model that uses DNA methylation patterns may help identify the origin of cancers of unknown primary

medicalxpress - A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research …

AI Summary: A machine‑learning model trained on DNA methylation signatures can assign tissue‑of‑origin for cancers of unknown primary with promising accuracy. The approach could speed diagnosis, guide therapy choices and reduce reliance on invasive tests—handy when a tumor refuses to tell doctors where it came from.

#biotech #digitalhealth #oncology #cancerresearch #cancerscreening #genetics

ctDNA and AI for treatment monitoring and early detection

25 days / oncodaily

29 days / oncodaily

4 wks / oncodaily


Liquid biopsies and extracellular vesicles for early cancer detection

29 days / oncodaily

29 days / medicalxpress


Methylation-based ML to identify cancers' tissue of origin


All Other Stories

23 days / nature

4 wks / oncodaily


Back to Top / Saturday, April 25, 2026, 2:21 am / permalink 22752 / 12 stories in 5 wks /


Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61


Related Stories



Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 4 days

AI face photos may predict cancer survival years earlier / 29 days

National study to use genetic testing to guide cancer survivor follow-up / 22 days

MYC overactivity enables DNA repair and chemotherapy resistance in tumours / 13 days

Prosigna-guided OPTIMA trial shows chemo can be safely skipped in many ER+/HER2− breast cancers / 25 hrs

Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 43 hrs

Personalized glioblastoma vaccine shows early promise in trials / 18 days

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Healthcare, Supplements, Nutrition, Novo Nordisk and look for the RSS link.



NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.